RxDoctor Payments DataLook up a doctor →

Mark Tyson, MD

Urology · Scottsdale, AZNPI 1346568508

Payments from drug & device makers

$4,896,489in general payments, 2019–2025

Across 194 payments — averaging $25,240 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2.9M
  • Janssen Research & Development, LLC$1.1M
  • AstraZeneca$669K
  • Pfizer$108K
  • Ferring Pharmaceuticals AS$56K
  • Photocure Inc$32K
  • plus $75K from 15 others

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,896,489 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.

See all urology providers in Arizona

Medicare billing

Part B allowed, 2024
$1,193,952
Medicare patients
980
Services billed
5,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →